Stay updated on HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Sign up to get notified when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a Location entry for Gauteng, South Africa under Locations and updated the page revision from v3.3.2 to v3.3.3. The Gauteng Locations listing and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:44:56.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Publication notes now indicate that items are automatically filled from PubMed and may not be about the study. A revision tag for v3.3.2 was added, and the prior PubMed-origin wording and v3.2.0 revision note were removed.
    Difference
    0.1%
    Check dated 2025-11-24T17:45:43.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page; the study details and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:23:19.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    No additions or deletions were detected for the page; the content and layout appear unchanged in the provided screenshots.
    Difference
    0.5%
    Check dated 2025-11-03T09:56:36.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Core content updated with a funding-status notice and a new version number (v3.2.0); previous v3.1.0 was removed. If no other substantive changes, this primarily communicates operational status and a software version bump.
    Difference
    2%
    Check dated 2025-10-05T14:31:43.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a v3.1.0 release tag.
    Difference
    0.1%
    Check dated 2025-09-28T09:50:31.000Z thumbnail image

Stay in the know with updates to HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.